The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Waddill William D. since 2015.
This trader's CIK number is 1553338.
At the time of last reporting, Waddill William D. was the Officer of Protagonist Therapeutics, Inc. (stock ticker symbol PTGX).
Also see all insider trading activities at Protagonist Therapeutics, Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | PTGX | 0 | $0 | 8,000 | $454,000 | 0 | $0 |
2024 | PTGX | 0 | $0 | 36,975 | $1,366,636 | 36,975 | $388,137 |
2022 | PTGX | 0 | $0 | 0 | $0 | 12,000 | $103,080 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | CALA | 0 | $0 | 0 | $0 | 13,125 | $34,650 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | ARWR | 0 | $0 | 11,429 | $314,942 | 0 | $0 |
2023 | ARWR | 0 | $0 | 3,200 | $96,000 | 0 | $0 |
2022 | ARWR | 0 | $0 | 4,500 | $293,233 | 0 | $0 |
2021 | ARWR | 0 | $0 | 3,750 | $285,300 | 0 | $0 |
2020 | ARWR | 0 | $0 | 29,000 | $1,162,440 | 0 | $0 |
2019 | ARWR | 0 | $0 | 8,500 | $125,545 | 0 | $0 |
1. Protagonist Therapeutics, Inc (PTGX)
2. Calithera Biosciences, Inc. (CALA)
3. Arrowhead Pharmaceuticals, Inc. (ARWR)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-27 | PTGX | Sale | 4,000 | 59.25 | 237,000 |
2025-03-17 | PTGX | Sale | 4,000 | 54.25 | 217,000 |
2024-09-10 | PTGX | Sale | 8,000 | 45.00 | 360,000 |
2024-09-10 | PTGX | Option Ex | 8,000 | 12.88 | 103,040 |
2024-07-24 | PTGX | Option Ex | 8,000 | 12.88 | 103,040 |
2024-07-24 | PTGX | Sale | 8,000 | 40.00 | 320,000 |
2024-06-07 | PTGX | Option Ex | 8,000 | 12.88 | 103,040 |
2024-06-07 | PTGX | Sale | 8,000 | 35.00 | 280,000 |
2024-03-01 | PTGX | Option Ex | 12,975 | 6.09 | 79,017 |
2024-03-01 | PTGX | Sale | 12,975 | 31.34 | 406,636 |
2022-05-03 | PTGX | Option Ex | 12,000 | 8.59 | 103,080 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-07-14 | CALA | Option Ex | 13,125 | 2.64 | 34,650 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-12-16 | ARWR | Sale | 3,748 | 21.90 | 82,081 |
2024-12-17 | ARWR | Sale | 3,747 | 22.04 | 82,583 |
2024-01-11 | ARWR | Sale | 3,934 | 38.20 | 150,278 |
2023-01-09 | ARWR | Sale | 3,200 | 30.00 | 96,000 |
2022-01-03 | ARWR | Sale | 4,500 | 65.16 | 293,233 |
2021-01-04 | ARWR | Sale | 3,750 | 76.08 | 285,300 |
2020-12-10 | ARWR | Sale | 3,000 | 70.80 | 212,400 |
2020-05-11 | ARWR | Sale | 26,000 | 36.54 | 950,040 |
2019-01-11 | ARWR | Sale | 8,500 | 14.77 | 125,545 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Waddill William D. (Officer of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.